Send me a link:

*Text messaging rates may apply.

 Dow Up0.36% Nasdaq Up0.71%

Spectrum Pharmaceuticals, Inc. (SPPI)

-NMS
7.06 Down 0.02(0.28%) 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue 40,124   41,516   42,439   33,232  
Cost of Revenue6,278  6,309  8,221  7,268  
Gross Profit 33,846   35,207   34,218   25,964  
Operating Expenses
Research Development29,497  10,760  13,567  10,460  
Selling General and Administrative23,403  25,714  29,003  22,584  
Non Recurring -   -   -   -  
Others5,360  5,245  4,935  5,449  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (24,414) (6,512) (13,287) (12,529)
Income from Continuing Operations
Total Other Income/Expenses Net(1,082)5,079  743  (584)
Earnings Before Interest And Taxes(25,496)(3,625)(12,544)(13,113)
Interest Expense2,067   -   -  (421)
Income Before Tax(27,563)(3,625)(12,544)(12,692)
Income Tax Expense78  35,747  (4,939)(2,970)
Minority Interest -   -   -   -  
Net Income From Continuing Ops(27,641)(39,372)(7,605)(9,722)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (27,641) (39,372) (7,605) (9,722)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (27,641) (39,372) (7,605) (9,722)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.